Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 22, 2014
"We achieved excellent third quarter results,” said Mike Mahoney, Boston Scientific chairman and CEO
-
Oct 21, 2014World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients with Chronic Pain
World's first 32-contact SCS surgical leads designed to provide more focused pain relief for patients with chronic pain
-
Oct 20, 2014First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease
PLATINUM diversity trial evaluating performance in women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease
-
Oct 16, 2014The innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems
Innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems
-
Oct 8, 2014Comprehensive Clinical Data from Randomized Trials Reviewed
Comprehensive clinical data from randomized trials reviewed
-
Oct 1, 2014
Boston Scientific will webcast its conference call discussing financial results and business highlights for Q3 ended September 30, 2014. Learn how to tune in.
-
Sep 23, 2014Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval
Data from REPRISE III clinical trial designed to support U.S. regulatory approval
-
Sep 17, 2014Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life
First DBS system to offer precise neural targeting and a 25-year battery life
-
Sep 15, 2014No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year
No cases of moderate or severe paravalvular aortic regurgitation at one year
-
Sep 10, 2014Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease
Data will focus on areas of significant unmet patient need, including Coronary Artery Disease and Aortic Valve Disease
-
Sep 3, 2014
Boston Scientific will participate in the upcoming healthcare conference on September 17, 2014 in London
-
Sep 2, 2014
Acquisition allows Boston Scientific to offer a more complete portfolio of solutions to treat challenging vascular conditions
-
Aug 30, 2014Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
-
Aug 25, 2014
Boston Scientific will participate in the healthcare conference on September 8 in New York
-
Aug 19, 2014Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator™ RotaWire™
Companies reach agreement to develop a new and differentiated FFR guidewire and next generation Boston Scientific Rotablator™ RotaWire™
-
Jul 24, 2014
"We had a strong second quarter, delivering balanced growth across our divisions," said CEO Mike Mahoney
-
Jul 23, 2014Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease
Innovative technology adds to company's leading portfolio of treatment options for Coronary Artery Disease
-
Jul 22, 2014Easy to Use Imaging System to Support Planned Intravascular Ultrasound and Fractional Flow Reserve Products
Easy to use imaging system to support planned intravascular ultrasound and fractional flow reserve products
-
Jul 21, 2014Advanced Bare-Metal Stent Provides Additional Treatment Option for Interventional Cardiologists and Patients
Advanced bare-metal stent provides additional treatment option for interventional cardiologists and patients
-
Jul 14, 2014European Launch Means Physicians Can Now Choose From Three Available Valve Sizes To Match Patient Anatomy More Precisely
European launch means physicians can now choose from three available valve sizes to match patient anatomy more precisely
-
Jul 14, 2014Innovative Technology Strengthens Company's Leading Portfolio of Solutions for Peripheral Vascular Disease
Innovative technology strengthens company's leading portfolio of solutions for peripheral vascular disease
-
Jul 1, 2014
Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ended June 30, 2014. Learn how to tune in.
-
Jun 11, 2014Data Presented at the 18th International Congress of Parkinson's Disease and Movement Disorders Demonstrate Highly Significant Improvement in Motor Function for Patients with Parkinson's Disease
Data presented at the 18th International Congress of Parkinson's Disease and Movement Disorders demonstrate highly significant improvement in motor function for patients with Parkinson's Disease
-
Jun 10, 2014Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease
Data presented at the International Congress of Parkinson's Disease and Movement Disorders demonstrate superior therapeutic window for the treatment of Parkinson's Disease
-
Jun 4, 2014
Registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world